NovartisUS Profile Banner
Novartis US Profile
Novartis US

@NovartisUS

Followers
3K
Following
87
Media
101
Statuses
380

An innovative medicines company working to reimagine medicine. See our community guidelines: https://t.co/NHpARWg6Vn.

United States
Joined March 2020
Don't wanna be here? Send us removal request.
@NovartisUS
Novartis US
20 days
RT @NYSE: The NYSE welcomes @ZEROCancer & @Novartis to celebrate Blitz the Barriers—which aims to be the most ambitious prostate cancer ini….
0
5
0
@NovartisUS
Novartis US
20 days
Together with @ZEROCancer and partners, we are sounding the bell to break down barriers in #ProstateCancer. Today, we joined the opening ceremony at the @NYSE to introduce real change for men’s health. 🎉. Learn more about Blitz The Barriers: #NYSE
Tweet media one
Tweet media two
Tweet media three
0
0
2
@NovartisUS
Novartis US
1 month
RT @NovartisNews: #News: Phase III PSMAddition trial demonstrates statistically significant and clinically meaningful rPFS benefit in patie….
0
2
0
@NovartisUS
Novartis US
1 month
#NEWS: We are sharing a new sub-analysis of data on patients with HR+/HER2- early #breastcancer across various ages, including younger patients. Learn more: . #NovartisUS #ASCO25 #BCSM
3
1
0
@NovartisUS
Novartis US
1 month
From reimagining the impossible to forging partnerships that make us unstoppable as a community, see how we are #ReimaginingMedicine, together.​ . Learn more: #NovartisUS
1
0
1
@NovartisUS
Novartis US
2 months
As a local sponsor of @LLSusa #BloodCancer Conferences, we're grateful to partner with a group whose commitment to the blood cancer community mirrors our own, especially in empowering people living with chronic myeloid leukemia to speak up about their treatment journeys.
Tweet media one
0
0
3
@NovartisUS
Novartis US
2 months
#News: We’re excited to announce our upcoming oncology and hematology data that has been recently accepted at @ASCO Annual Meeting and @EHA_Hematology 2025 Congress. . #ASCO25 #EHA2025
0
0
4
@NovartisUS
Novartis US
2 months
As a member of @BCpolicyNOW, we’re raising awareness about the need to remove barriers to #breastcancer care through policies like the Access for Breast Cancer Diagnosis (ABCD) Act. Now we need to get Congress’s attention: #ReimaginingMedicine.
@BCpolicyNOW
Alliance for Breast Cancer Policy
2 months
@KomenAdvocacy @NovartisUS @elaine1walsh "The #ABCDAct is so essential because we have a problem: access to diagnosis is not guaranteed. Not because tests don’t exist, or doctors don’t care. It’s because patients can't afford.". @ACSCAN's Angela Sailor explains how the ABCD Act could help address the access issue for
Tweet media one
3
0
1
@NovartisUS
Novartis US
3 months
#News: We are expanding our US-based manufacturing and R&D footprint with a planned $23B investment over the next 5 years. 🔗 . #NovartisUS
5
7
10
@NovartisUS
Novartis US
3 months
Today’s regulatory milestone represents a step forward for patients, loved ones and providers who have been in need of more options to treat advanced prostate cancer earlier. #NovartisUS #ReimaginingMedicine
1
2
6
@NovartisUS
Novartis US
4 months
We are joining the roster as the @NFL’s first-ever corporate pharmaceutical partner! This collaboration is designed to bring critical health conversations to the forefront, making preventive care and early detection more accessible for fans everywhere. 🤝.
2
2
8
@NovartisUS
Novartis US
4 months
Partnering with @SusanGKomen and other leading advocacy voices to launch the Alliance for Breast Cancer Policy is a testament to our collective commitment to improving outcomes for people affected by #breastcancer. @BCpolicyNOW.
1
0
4
@NovartisUS
Novartis US
4 months
Novartis highlights commitment to hidradenitis suppurativa and chronic spontaneous urticaria at AAAAI and AAD annual congresses.
Tweet media one
0
1
4
@NovartisUS
Novartis US
5 months
Partnering with @ZEROCancer is a demonstration of our deep commitment to closing gaps faced by people with #prostatecancer and supporting better health care. #ReimaginingMedicine.
1
0
1
@NovartisUS
Novartis US
5 months
Today, we are proud to announce our role as Lead Founding Partner of .@ZEROCancer's Blitz The Barriers. Together, we’ll improve outcomes among populations who are greatly impacted by #prostatecancer. #ReimaginingMedicine.
0
1
3
@NovartisUS
Novartis US
5 months
We reflected on the importance of patient voices during a summit with medical experts and advocates at #ASCO2024. Open dialogue with care teams is crucial to improving care for those living with chronic myeloid leukemia. Together, we can make a difference. 🔗Learn more:
0
0
0
@NovartisUS
Novartis US
7 months
Innovation is at the heart of what we do. This #ASH24 and #SABCS24, we showcased our commitment to pushing the boundaries of science to help shape a future where patients living with cancer have greater hope. #NovartisUS #ReimaginingMedicine
1
1
0
@NovartisUS
Novartis US
7 months
Fear. Courage. Hope. These are just a few feelings expressed by people with #breastcancer at the Novartis exhibit at #SABCS24. These raw and honest perspectives can help others feel less alone in their personal journey, and inspire all of us to continue reimagining medicine,
Tweet media one
1
0
1
@NovartisUS
Novartis US
7 months
This week at #SABCS24, we will share our latest clinical and real-world data in patients with #EBC at high risk of recurrence, regardless of nodal involvement. We’re proud to help evolve care, so many more people can lower their risk of cancer recurrence. #bcsm
Tweet media one
1
0
1